LobbyingSpina Bifida Association of America lobbying by quarter
Spina Bifida Association of America's latest lobbying report covers Q2 2026, at $33.5K. The four quarters Q4 2025–Q3 2026 total $131K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medical/Disease Research/Clinical Labs.
Spina Bifida Association of America
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $131K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $38.4K | 1 |
| Q1 2023 | $70K | 1 |
| Q2 2023 | $45.5K | 1 |
| Q3 2023 | $40.7K | 1 |
| Q4 2023 | $48K | 1 |
| Q1 2024 | $75.6K | 1 |
| Q2 2024 | $32.4K | 1 |
| Q3 2024 | $28.4K | 1 |
| Q4 2024 | $25.1K | 1 |
| Q1 2025 | $53.1K | 1 |
| Q2 2025 | $34.1K | 1 |
| Q3 2025 | $30.3K | 1 |
| Q4 2025 | $39.8K | 1 |
| Q1 2026 | $57.7K | 1 |
| Q2 2026 | $33.5K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$326.4K · 15 reports
- Medical research and clinical labs$326.4K · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Disease Control & Prevention (CDC)15 reports
- Centers For Medicare and Medicaid Services (CMS)15 reports
- HOUSE OF REPRESENTATIVES15 reports
- Natl Institutes of Health (NIH)15 reports
- SENATE15 reports
- Health & Human Services, Dept of (HHS)6 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseSpina Bifida Association of America | $652.7K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| SARA STRUWE | Chief Executive Officer | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/31for Q2 | In-house | $33.5K |
| 04/17for Q1 | In-house | $57.7K |
| 01/29for Q4 2025 | In-house | $39.8K |
| 25/10/20for Q3 2025 | In-house | $30.3K |
| 25/07/21for Q2 2025 | In-house | $34.1K |
| 25/05/07for Q1 2025 | In-house | $53.1K |
| 25/05/06for Q1 2025 | In-house | $53.1K |
| 25/01/30for Q4 2024 | In-house | $25.1K |
| 24/10/24for Q3 2024 | In-house | $28.4K |
| 24/07/19for Q2 2024 | In-house | $32.4K |
| 24/04/18for Q1 2024 | In-house | $75.6K |
| 24/01/29for Q4 2023 | In-house | $48K |
| 23/10/25for Q3 2023 | In-house | $40.7K |
| 23/07/14for Q2 2023 | In-house | $45.5K |
| 23/04/19for Q1 2023 | In-house | $70K |
| 23/01/24for Q4 2022 | In-house | $38.4K |